Search clinical trials for: nasal potential difference (NPD)

Total 7109 results

Children's Hospital of Philadelphia

Completed

Nasal Potential Difference (NPD) for the Diagnosis of Cystic Fibrosis

Cystic Fibrosis

United States
Hadassah Medical Organization

Unknown

NPD Measurement in Infants

Cystic Fibrosis
Hadassah Medical Organization

Unknown

NPD Measurements in PSC Patients

Primary Sclerosing Cholangitis

Israel
Charite University, Berlin, Germany
Hannover Medical School; Heidelberg University; University of Giessen

Recruiting

Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators (Modulate-CF)

Cystic Fibrosis

Germany
University of Alabama at Birmingham
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis

Rhinosinusitis

United States
Beth Israel Deaconess Medical Center
Boston Children's Hospital

Completed

NPDT Evaluation in Children With CFTR and (PSC) (NPD)

Primary Sclerosing Cholangitis | Inflammatory Bowel Disease

United States
Analgesic Solutions
Grünenthal GmbH

Completed

Training "Pain Connoisseurs" for Efficient Analgesic Proof-of-Concept Studies

Painful Diabetic Neuropathy (PDN)

United States
He Xia

Unknown

Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma (NPC-RCT-WCRT)

Nasopharyngeal Carcinoma
ProQR Therapeutics
European Commission

Completed

Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation

Cystic Fibrosis

United States, France, Belgium
Ramsey, Bonnie, MD
Cystic Fibrosis Foundation; CF Therapeutics Development Network Coordinating... and other collaborators

Completed

Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis (SEER)

Cystic Fibrosis

United States
Sun Yat-sen University
The First Affiliated Hospital of Guangdong Pharmaceutical University; Guangzhou... and other collaborators

Completed

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Reckitt Benckiser LLC

Completed

Evaluation of Tolerance and Acceptability of a Coated Condom

Tolerance and Acceptability of a New Condom Coating

United Kingdom
Children's Hospital Medical Center, Cincinnati

Recruiting

Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials (Nof1)

Cystic Fibrosis

United States
AstraZeneca

Completed

Study to Evaluate the Analgesic Efficacy of 28 Days' Oral Administration of AZD2066 Compared With Placebo in Patients With Painful Diabetic Neuropathy

Pain | Diabetic Neuropathy

United States
Hannover Medical School
Heidelberg University; University of Giessen

Completed

ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor (OrkambiFacts)

Cystic Fibrosis

Germany
Daping Hospital and the Research Institute of Surgery...

Unknown

Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer

Cervical Cancer | Complications

China
Theragenics Corporation

Unknown

Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System

Macular Degeneration | Choroidal Neovascularization

United States
Pamlab, L.L.C.
HealthCore, Inc.

Completed

Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathy (DPN)

United States
Lateral Pharma Pty Ltd

Completed

Oral LAT8881 in Neuropathic Pain

Neuropathic Pain | Diabetic Peripheral Neuropathy (DPN) | Post Herpetic Neuralgia (PHN)

Australia, United Kingdom
Riphah International University

Recruiting

BRACE(Balance, Resistance, Aerobic and Cognitive Exercise) Protocol for Diabetic).Peripheral Neuropathic Patients.

Diabetic Peripheral Neuropathy (DPN)

Pakistan
Haisco Pharmaceutical Group Co., Ltd.

Completed

Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN

Paresthesia | Diabetic Peripheral Neuropathy (DPN)

China
Sohag University

Not yet recruiting

Diabetic Foot Self Care

Diabetic Foot
Affiliated Cancer Hospital & Institute of Guangzhou...

Recruiting

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Massachusetts General Hospital

Recruiting

Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe

Inflammatory Bowel Diseases | Crohn Disease | Permeability; Increased | Inflammatory Disease | Environmental Enteropathy

United States
National Jewish Health
Johns Hopkins University; Children's Hospital of Philadelphia; University of... and other collaborators

Terminated

Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis) (GPBA)

Cystic Fibrosis

United States
Novartis Pharmaceuticals

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis

Cystic Fibrosis

United States
University of Miami
James and Esther King Biomedical Research Program

Terminated

Evaluation of Acute and Subacute Effects of Nicotine Free Electronic Cigarette(NCFE) Vapors

Healthy Lifetime Non-smokers

United States
National Jewish Health

Completed

Effects of Sildenafil on CFTR-dependent Ion Transport Activity

Cystic Fibrosis

United States
Cliniques universitaires Saint-Luc- Université...

Terminated

Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?

Cystic Fibrosis

Belgium
Assistance Publique - Hôpitaux de Paris
Actelion; CRCM (Centres de Ressources et de Compétences de la Mucoviscidose)

Completed

Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the F508del Mutation (MIGLUSTAT-CF)

Cystic Fibrosis

France
Cliniques universitaires Saint-Luc- Université...

Completed

Does a Nasal Instillation of Miglustat Normalize the Nasal Potential Difference in Cystic Fibrosis Patients ?

Cystic Fibrosis

Belgium
Actelion

Terminated

Miglustat / OGT 918 in the Treatment of Cystic Fibrosis

Cystic Fibrosis

Spain
Alexion Pharmaceuticals

Terminated

Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency

Lysosomal Acid Lipase Deficiency

United Kingdom, Finland, United States, Italy
Alexion Pharmaceuticals

Completed

Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency

Wolman Disease | Lysosomal Acid Lipase Deficiency

United Kingdom, France, United States, Egypt, Ireland
University of Alberta

Recruiting

Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences (STARS)

Vasodilation | Vasoconstriction

Canada
University of Florida

Recruiting

The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults

Pain

United States
Rutgers, The State University of New Jersey

Recruiting

Afferent Neurocardiac Signals, Cue Reactivity, and Cognitive Control

Binge Drinking

United States
Institut Pasteur
Hopital Lariboisière

Recruiting

Study of the Evolution of Olfactory Disorders in Patients With Persistent Loss of Smell Following COVID-19 (ETOC)

SARS-CoV-2 Acute Respiratory Disease

France
National Cancer Institute (NCI)

Active, not recruiting

Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
Massachusetts General Hospital
Bill and Melinda Gates Foundation

Enrolling by invitation

Feasibility, Safety and Utility of Endomicroscopy to Study the Intestines of Unsedated Infants at University of Virginia (UVa)

Healthy

United States
University of Alberta

Completed

Sex Differences in Sympathetic Vascular Reactivity at High Altitude

Vasodilation | Vasoconstriction

Canada
Technical University of Munich
German Research Foundation

Completed

Intra- and Inter-individual Differences of Pain

Experimental Pain in Healthy Human Subjects

Germany
University of Alberta

Completed

Sex Differences in Sympathetic Activity and Vascular Reactivity During Acute and Chronic Hypoxia.

Vasodilation | Vasoconstriction

Canada
Taipei Medical University Shuang Ho Hospital
Ministry of Science and Technology, Taiwan

Completed

Optimal Anesthesia for Morbidly Obese Patients

Obesity | Anesthesia

Taiwan
University of Florida
GlaxoSmithKline; Food and Drug Administration (FDA)

Completed

Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays

Hypersensitivity

United States
Assistance Publique - Hôpitaux de Paris

Completed

Bronchial Trans-epithelial Transport in Patients With Idiopathic Multiple Dilations of the Bronchi (EPITRANS)

Idiopathic Dilation of the Bronchi

France
Rush University Medical Center
Advanced Rx

Active, not recruiting

Potential for Cortisol Suppression With the Use of High Volume Nasal Mometasone Irrigations in Varying Dosages.

Chronic Rhinosinusitis (Diagnosis)

United States
Deborah Gentile
Merck Sharp & Dohme LLC

Completed

Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds

Upper Respiratory Infection

United States
The University of Texas at Arlington

Completed

The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction

Cardiovascular Diseases | Cardiovascular Risk Factor | Vasoconstriction

United States
University Hospital, Antwerp

Unknown

Study of Probiotic Potential of Lactobacillus Strains in the Upper Respiratory Tract After Nasal Spray Application

Chronic Rhinosinusitis (Diagnosis) | Probiotics | Healthy Volunteers | Nasal Disease | Sprays

Belgium

Search clinical trials for: nasal potential difference (NPD)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations